NOVACYT SIGNS STRATEGIC ALLIANCE WITH CEPHEID FOR HPV DIAGNOSTICS IN LATIN AMERICA

strategic-alliance-agreement-with-cepheid Paris, France and Cambridge, UK – 4th October 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces it has entered into a strategic alliance with Cepheid Inc., a leading international molecular diagnostics company, to introduce a complete Human Papillomavirus (HPV) diagnostic system into Latin America.

Visit Page

Novacyt appoints Anthony Dyer as Finance Director

Novacyt (Mmemo: ALNOV – FR0010397232) announces that Anthony Dyer will become Finance Director. Download press release

Visit Page

Novacyt strengthens board

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics is pleased to announce the addition of new members to its Board as the Company prepares for the next stages of growth. Download press release

Visit Page

Novacyt appoints new Group Commercial Director

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has appointed Manuela Gazzard as Commercial Director. Download press release

Visit Page